A Creighton University finance expert expects Warren Buffett’s cancer diagnosis to be the dominant topic at the upcoming Berkshire Hathaway shareholders’ meeting.
Buffett, the longtime Berkshire CEO, announced Tuesday he has stage one prostate cancer. Berkshire Hathaway Class A and B stock finished down about one and a half percent Tuesday and Wednesday.